205 studies found for:    Open Studies | "Psoriasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Psoriasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
2 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
3 Recruiting An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
4 Recruiting Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Biological: Etanercept;   Other: Placebo
5 Recruiting A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
6 Not yet recruiting TSO for Plaque Psoriasis
Condition: Plaque Psoriasis
Intervention: Biological: Trichuris Suis Ova
7 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
8 Recruiting Diabetes and Psoriasis
Conditions: Diabetes;   Psoriasis
Intervention: Other: PASI and HOMA index
9 Recruiting Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome;   Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
10 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
11 Recruiting Vascular Inflammation in Psoriasis - Extension Study
Conditions: Psoriasis;   Cardiovascular Disease
Intervention: Drug: Adalimumab
12 Recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
13 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
14 Recruiting A Study Evaluating The Efficacy And Safety oO CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: placebo;   Drug: CP-690,550
15 Recruiting A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Guselkumab;   Drug: Placebo for ustekinumab;   Drug: Placebo for guselkumab
16 Recruiting miRNAs and mRNAs in Psoriasis
Condition: Psoriasis
Intervention: Other: 4 mm punch biopsies
17 Unknown  Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
18 Not yet recruiting The Association Between Psoriasis and Intestinal Bacterial Population
Condition: Psoriasis
Intervention:
19 Recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
20 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years